The global Sodium Nitroprusside Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sodium Nitroprusside Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Sodium nitroprusside injection is a medication used in the management of acute hypertension. It is a potent vasodilator and is administered as an IV infusion with intensive monitoring in place.

The North American market for Sodium Nitroprusside Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Sodium Nitroprusside Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Sodium Nitroprusside Injection include Pfizer, Akorn, Inc., Nexus Pharmaceuticals, Meitheal Pharmaceuticals, Slate Run Pharmaceuticals, Exela Pharma Sciences, Yuekang Pharmaceutical Group, Kaifeng Connaught Pharmaceutical, China Resources Shuanghe Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Sodium Nitroprusside Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sodium Nitroprusside Injection. The Sodium Nitroprusside Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sodium Nitroprusside Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sodium Nitroprusside Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sodium Nitroprusside Injection Market Report

Report Metric	Details
Report Name	Sodium Nitroprusside Injection Market
Segment by Type	Dry Powder Injection Liquid Injection
by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Akorn, Inc., Nexus Pharmaceuticals, Meitheal Pharmaceuticals, Slate Run Pharmaceuticals, Exela Pharma Sciences, Yuekang Pharmaceutical Group, Kaifeng Connaught Pharmaceutical, China Resources Shuanghe Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sodium Nitroprusside Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sodium Nitroprusside Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Sodium Nitroprusside Injection Market report?

Ans: The main players in the Sodium Nitroprusside Injection Market are Pfizer, Akorn, Inc., Nexus Pharmaceuticals, Meitheal Pharmaceuticals, Slate Run Pharmaceuticals, Exela Pharma Sciences, Yuekang Pharmaceutical Group, Kaifeng Connaught Pharmaceutical, China Resources Shuanghe Pharmaceutical

What are the Application segmentation covered in the Sodium Nitroprusside Injection Market report?

Ans: The Applications covered in the Sodium Nitroprusside Injection Market report are Hospital, Clinic

What are the Type segmentation covered in the Sodium Nitroprusside Injection Market report?

Ans: The Types covered in the Sodium Nitroprusside Injection Market report are Dry Powder Injection, Liquid Injection

1 Sodium Nitroprusside Injection Market Overview

1.1 Product Definition

1.2 Sodium Nitroprusside Injection by Type

1.2.1 Global Sodium Nitroprusside Injection Market Value by Type: 2025 vs 2032

1.2.2 Dry Powder Injection

1.2.3 Liquid Injection

1.3 Sodium Nitroprusside Injection by Application

1.3.1 Global Sodium Nitroprusside Injection Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Sodium Nitroprusside Injection Market Size Estimates and Forecasts

1.4.1 Global Sodium Nitroprusside Injection Revenue 2021–2032

1.4.2 Global Sodium Nitroprusside Injection Sales 2021–2032

1.4.3 Global Sodium Nitroprusside Injection Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Sodium Nitroprusside Injection Market Competition by Manufacturers

2.1 Global Sodium Nitroprusside Injection Sales Market Share by Manufacturers (2021–2026)

2.2 Global Sodium Nitroprusside Injection Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Sodium Nitroprusside Injection Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Sodium Nitroprusside Injection, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Sodium Nitroprusside Injection, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Sodium Nitroprusside Injection, Product Types and Applications

2.7 Global Key Manufacturers of Sodium Nitroprusside Injection, Date of Entry into the Industry

2.8 Global Sodium Nitroprusside Injection Market Competitive Situation and Trends

2.8.1 Global Sodium Nitroprusside Injection Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Sodium Nitroprusside Injection Players Market Share by Revenue

2.8.3 Global Sodium Nitroprusside Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sodium Nitroprusside Injection Market Scenario by Region

3.1 Global Sodium Nitroprusside Injection Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Sodium Nitroprusside Injection Sales by Region: 2021–2032

3.2.1 Global Sodium Nitroprusside Injection Sales by Region: 2021–2026

3.2.2 Global Sodium Nitroprusside Injection Sales by Region: 2027–2032

3.3 Global Sodium Nitroprusside Injection Revenue by Region: 2021–2032

3.3.1 Global Sodium Nitroprusside Injection Revenue by Region: 2021–2026

3.3.2 Global Sodium Nitroprusside Injection Revenue by Region: 2027–2032

3.4 North America Sodium Nitroprusside Injection Market Facts & Figures by Country

3.4.1 North America Sodium Nitroprusside Injection Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Sodium Nitroprusside Injection Sales by Country (2021–2032)

3.4.3 North America Sodium Nitroprusside Injection Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Sodium Nitroprusside Injection Market Facts & Figures by Country

3.5.1 Europe Sodium Nitroprusside Injection Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Sodium Nitroprusside Injection Sales by Country (2021–2032)

3.5.3 Europe Sodium Nitroprusside Injection Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sodium Nitroprusside Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Sodium Nitroprusside Injection Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Sodium Nitroprusside Injection Sales by Region (2021–2032)

3.6.3 Asia Pacific Sodium Nitroprusside Injection Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Sodium Nitroprusside Injection Market Facts & Figures by Country

3.7.1 Latin America Sodium Nitroprusside Injection Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Sodium Nitroprusside Injection Sales by Country (2021–2032)

3.7.3 Latin America Sodium Nitroprusside Injection Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Sodium Nitroprusside Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Sodium Nitroprusside Injection Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Sodium Nitroprusside Injection Sales by Country (2021–2032)

3.8.3 Middle East and Africa Sodium Nitroprusside Injection Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Sodium Nitroprusside Injection Sales by Type (2021–2032)

4.1.1 Global Sodium Nitroprusside Injection Sales by Type (2021–2026)

4.1.2 Global Sodium Nitroprusside Injection Sales by Type (2027–2032)

4.1.3 Global Sodium Nitroprusside Injection Sales Market Share by Type (2021–2032)

4.2 Global Sodium Nitroprusside Injection Revenue by Type (2021–2032)

4.2.1 Global Sodium Nitroprusside Injection Revenue by Type (2021–2026)

4.2.2 Global Sodium Nitroprusside Injection Revenue by Type (2027–2032)

4.2.3 Global Sodium Nitroprusside Injection Revenue Market Share by Type (2021–2032)

4.3 Global Sodium Nitroprusside Injection Price by Type (2021–2032)

5 Segment by Application

5.1 Global Sodium Nitroprusside Injection Sales by Application (2021–2032)

5.1.1 Global Sodium Nitroprusside Injection Sales by Application (2021–2026)

5.1.2 Global Sodium Nitroprusside Injection Sales by Application (2027–2032)

5.1.3 Global Sodium Nitroprusside Injection Sales Market Share by Application (2021–2032)

5.2 Global Sodium Nitroprusside Injection Revenue by Application (2021–2032)

5.2.1 Global Sodium Nitroprusside Injection Revenue by Application (2021–2026)

5.2.2 Global Sodium Nitroprusside Injection Revenue by Application (2027–2032)

5.2.3 Global Sodium Nitroprusside Injection Revenue Market Share by Application (2021–2032)

5.3 Global Sodium Nitroprusside Injection Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Pfizer Sodium Nitroprusside Injection Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Akorn, Inc.

6.2.1 Akorn, Inc. Company Information

6.2.2 Akorn, Inc. Description and Business Overview

6.2.3 Akorn, Inc. Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Akorn, Inc. Sodium Nitroprusside Injection Product Portfolio

6.2.5 Akorn, Inc. Recent Developments/Updates

6.3 Nexus Pharmaceuticals

6.3.1 Nexus Pharmaceuticals Company Information

6.3.2 Nexus Pharmaceuticals Description and Business Overview

6.3.3 Nexus Pharmaceuticals Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Nexus Pharmaceuticals Sodium Nitroprusside Injection Product Portfolio

6.3.5 Nexus Pharmaceuticals Recent Developments/Updates

6.4 Meitheal Pharmaceuticals

6.4.1 Meitheal Pharmaceuticals Company Information

6.4.2 Meitheal Pharmaceuticals Description and Business Overview

6.4.3 Meitheal Pharmaceuticals Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Meitheal Pharmaceuticals Sodium Nitroprusside Injection Product Portfolio

6.4.5 Meitheal Pharmaceuticals Recent Developments/Updates

6.5 Slate Run Pharmaceuticals

6.5.1 Slate Run Pharmaceuticals Company Information

6.5.2 Slate Run Pharmaceuticals Description and Business Overview

6.5.3 Slate Run Pharmaceuticals Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Slate Run Pharmaceuticals Sodium Nitroprusside Injection Product Portfolio

6.5.5 Slate Run Pharmaceuticals Recent Developments/Updates

6.6 Exela Pharma Sciences

6.6.1 Exela Pharma Sciences Company Information

6.6.2 Exela Pharma Sciences Description and Business Overview

6.6.3 Exela Pharma Sciences Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Exela Pharma Sciences Sodium Nitroprusside Injection Product Portfolio

6.6.5 Exela Pharma Sciences Recent Developments/Updates

6.7 Yuekang Pharmaceutical Group

6.7.1 Yuekang Pharmaceutical Group Company Information

6.7.2 Yuekang Pharmaceutical Group Description and Business Overview

6.7.3 Yuekang Pharmaceutical Group Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Yuekang Pharmaceutical Group Sodium Nitroprusside Injection Product Portfolio

6.7.5 Yuekang Pharmaceutical Group Recent Developments/Updates

6.8 Kaifeng Connaught Pharmaceutical

6.8.1 Kaifeng Connaught Pharmaceutical Company Information

6.8.2 Kaifeng Connaught Pharmaceutical Description and Business Overview

6.8.3 Kaifeng Connaught Pharmaceutical Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Kaifeng Connaught Pharmaceutical Sodium Nitroprusside Injection Product Portfolio

6.8.5 Kaifeng Connaught Pharmaceutical Recent Developments/Updates

6.9 China Resources Shuanghe Pharmaceutical

6.9.1 China Resources Shuanghe Pharmaceutical Company Information

6.9.2 China Resources Shuanghe Pharmaceutical Description and Business Overview

6.9.3 China Resources Shuanghe Pharmaceutical Sodium Nitroprusside Injection Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 China Resources Shuanghe Pharmaceutical Sodium Nitroprusside Injection Product Portfolio

6.9.5 China Resources Shuanghe Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sodium Nitroprusside Injection Industry Chain Analysis

7.2 Sodium Nitroprusside Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sodium Nitroprusside Injection Production Mode & Process Analysis

7.4 Sodium Nitroprusside Injection Sales and Marketing

7.4.1 Sodium Nitroprusside Injection Sales Channels

7.4.2 Sodium Nitroprusside Injection Distributors

7.5 Sodium Nitroprusside Injection Customer Analysis

8 Sodium Nitroprusside Injection Market Dynamics

8.1 Sodium Nitroprusside Injection Industry Trends

8.2 Sodium Nitroprusside Injection Market Drivers

8.3 Sodium Nitroprusside Injection Market Challenges

8.4 Sodium Nitroprusside Injection Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Akorn

Nexus Pharmaceuticals

Meitheal Pharmaceuticals

Slate Run Pharmaceuticals

Exela Pharma Sciences

Yuekang Pharmaceutical Group

China Resources Shuanghe Pharmaceutical

Kaifeng Connaught Pharmaceutical

List of Tables

Table 1. Global Sodium Nitroprusside Injection Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Sodium Nitroprusside Injection Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Sodium Nitroprusside Injection Market Competitive Situation by Manufacturers in 2025

Table 4. Global Sodium Nitroprusside Injection Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Sodium Nitroprusside Injection Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Sodium Nitroprusside Injection Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Sodium Nitroprusside Injection Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Sodium Nitroprusside Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Sodium Nitroprusside Injection, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Sodium Nitroprusside Injection, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Sodium Nitroprusside Injection, Product Types and Applications

Table 12. Global Key Manufacturers of Sodium Nitroprusside Injection, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sodium Nitroprusside Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sodium Nitroprusside Injection Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sodium Nitroprusside Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Sodium Nitroprusside Injection Sales by Region (K Units), 2021–2026

Table 18. Global Sodium Nitroprusside Injection Sales Market Share by Region (2021–2026)

Table 19. Global Sodium Nitroprusside Injection Sales by Region (K Units), 2027–2032

Table 20. Global Sodium Nitroprusside Injection Sales Market Share by Region (2027–2032)

Table 21. Global Sodium Nitroprusside Injection Revenue by Region (US$ Million), 2021–2026

Table 22. Global Sodium Nitroprusside Injection Revenue Market Share by Region (2021–2026)

Table 23. Global Sodium Nitroprusside Injection Revenue by Region (US$ Million), 2027–2032

Table 24. Global Sodium Nitroprusside Injection Revenue Market Share by Region (2027–2032)

Table 25. North America Sodium Nitroprusside Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Sodium Nitroprusside Injection Sales by Country (K Units), 2021–2026

Table 27. North America Sodium Nitroprusside Injection Sales by Country (K Units), 2027–2032

Table 28. North America Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2021–2026

Table 29. North America Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Sodium Nitroprusside Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Sodium Nitroprusside Injection Sales by Country (K Units), 2021–2026

Table 32. Europe Sodium Nitroprusside Injection Sales by Country (K Units), 2027–2032

Table 33. Europe Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Sodium Nitroprusside Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Sodium Nitroprusside Injection Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Sodium Nitroprusside Injection Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Sodium Nitroprusside Injection Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Sodium Nitroprusside Injection Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Sodium Nitroprusside Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Sodium Nitroprusside Injection Sales by Country (K Units), 2021–2026

Table 42. Latin America Sodium Nitroprusside Injection Sales by Country (K Units), 2027–2032

Table 43. Latin America Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Sodium Nitroprusside Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Sodium Nitroprusside Injection Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Sodium Nitroprusside Injection Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Sodium Nitroprusside Injection Revenue by Country (US$ Million), 2027–2032

Table 50. Global Sodium Nitroprusside Injection Sales (K Units) by Type (2021–2026)

Table 51. Global Sodium Nitroprusside Injection Sales (K Units) by Type (2027–2032)

Table 52. Global Sodium Nitroprusside Injection Sales Market Share by Type (2021–2026)

Table 53. Global Sodium Nitroprusside Injection Sales Market Share by Type (2027–2032)

Table 54. Global Sodium Nitroprusside Injection Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Sodium Nitroprusside Injection Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Sodium Nitroprusside Injection Revenue Market Share by Type (2021–2026)

Table 57. Global Sodium Nitroprusside Injection Revenue Market Share by Type (2027–2032)

Table 58. Global Sodium Nitroprusside Injection Price (US$/Unit) by Type (2021–2026)

Table 59. Global Sodium Nitroprusside Injection Price (US$/Unit) by Type (2027–2032)

Table 60. Global Sodium Nitroprusside Injection Sales (K Units) by Application (2021–2026)

Table 61. Global Sodium Nitroprusside Injection Sales (K Units) by Application (2027–2032)

Table 62. Global Sodium Nitroprusside Injection Sales Market Share by Application (2021–2026)

Table 63. Global Sodium Nitroprusside Injection Sales Market Share by Application (2027–2032)

Table 64. Global Sodium Nitroprusside Injection Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Sodium Nitroprusside Injection Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Sodium Nitroprusside Injection Revenue Market Share by Application (2021–2026)

Table 67. Global Sodium Nitroprusside Injection Revenue Market Share by Application (2027–2032)

Table 68. Global Sodium Nitroprusside Injection Price (US$/Unit) by Application (2021–2026)

Table 69. Global Sodium Nitroprusside Injection Price (US$/Unit) by Application (2027–2032)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Pfizer Sodium Nitroprusside Injection Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Akorn, Inc. Company Information

Table 76. Akorn, Inc. Description and Business Overview

Table 77. Akorn, Inc. Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Akorn, Inc. Sodium Nitroprusside Injection Product

Table 79. Akorn, Inc. Recent Developments/Updates

Table 80. Nexus Pharmaceuticals Company Information

Table 81. Nexus Pharmaceuticals Description and Business Overview

Table 82. Nexus Pharmaceuticals Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Nexus Pharmaceuticals Sodium Nitroprusside Injection Product

Table 84. Nexus Pharmaceuticals Recent Developments/Updates

Table 85. Meitheal Pharmaceuticals Company Information

Table 86. Meitheal Pharmaceuticals Description and Business Overview

Table 87. Meitheal Pharmaceuticals Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Meitheal Pharmaceuticals Sodium Nitroprusside Injection Product

Table 89. Meitheal Pharmaceuticals Recent Developments/Updates

Table 90. Slate Run Pharmaceuticals Company Information

Table 91. Slate Run Pharmaceuticals Description and Business Overview

Table 92. Slate Run Pharmaceuticals Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Slate Run Pharmaceuticals Sodium Nitroprusside Injection Product

Table 94. Slate Run Pharmaceuticals Recent Developments/Updates

Table 95. Exela Pharma Sciences Company Information

Table 96. Exela Pharma Sciences Description and Business Overview

Table 97. Exela Pharma Sciences Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Exela Pharma Sciences Sodium Nitroprusside Injection Product

Table 99. Exela Pharma Sciences Recent Developments/Updates

Table 100. Yuekang Pharmaceutical Group Company Information

Table 101. Yuekang Pharmaceutical Group Description and Business Overview

Table 102. Yuekang Pharmaceutical Group Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Yuekang Pharmaceutical Group Sodium Nitroprusside Injection Product

Table 104. Yuekang Pharmaceutical Group Recent Developments/Updates

Table 105. Kaifeng Connaught Pharmaceutical Company Information

Table 106. Kaifeng Connaught Pharmaceutical Description and Business Overview

Table 107. Kaifeng Connaught Pharmaceutical Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Kaifeng Connaught Pharmaceutical Sodium Nitroprusside Injection Product

Table 109. Kaifeng Connaught Pharmaceutical Recent Developments/Updates

Table 110. China Resources Shuanghe Pharmaceutical Company Information

Table 111. China Resources Shuanghe Pharmaceutical Description and Business Overview

Table 112. China Resources Shuanghe Pharmaceutical Sodium Nitroprusside Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. China Resources Shuanghe Pharmaceutical Sodium Nitroprusside Injection Product

Table 114. China Resources Shuanghe Pharmaceutical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Sodium Nitroprusside Injection Distributors List

Table 118. Sodium Nitroprusside Injection Customers List

Table 119. Sodium Nitroprusside Injection Market Trends

Table 120. Sodium Nitroprusside Injection Market Drivers

Table 121. Sodium Nitroprusside Injection Market Challenges

Table 122. Sodium Nitroprusside Injection Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sodium Nitroprusside Injection

Figure 2. Global Sodium Nitroprusside Injection Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Sodium Nitroprusside Injection Market Share by Type: 2025 & 2032

Figure 4. Dry Powder Injection Product Picture

Figure 5. Liquid Injection Product Picture

Figure 6. Global Sodium Nitroprusside Injection Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Sodium Nitroprusside Injection Market Share by Application: 2025 & 2032

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global Sodium Nitroprusside Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Sodium Nitroprusside Injection Market Size (US$ Million), 2021–2032

Figure 12. Global Sodium Nitroprusside Injection Sales (K Units), 2021–2032

Figure 13. Global Sodium Nitroprusside Injection Average Price (US$/Unit), 2021–2032

Figure 14. Sodium Nitroprusside Injection Report Years Considered

Figure 15. Sodium Nitroprusside Injection Sales Share by Manufacturers in 2025

Figure 16. Global Sodium Nitroprusside Injection Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Sodium Nitroprusside Injection Players: Market Share by Revenue in Sodium Nitroprusside Injection in 2025

Figure 18. Sodium Nitroprusside Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Sodium Nitroprusside Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Sodium Nitroprusside Injection Sales Market Share by Country (2021–2032)

Figure 21. North America Sodium Nitroprusside Injection Revenue Market Share by Country (2021–2032)

Figure 22. United States Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Sodium Nitroprusside Injection Sales Market Share by Country (2021–2032)

Figure 25. Europe Sodium Nitroprusside Injection Revenue Market Share by Country (2021–2032)

Figure 26. Germany Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. U.K. Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Sodium Nitroprusside Injection Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Sodium Nitroprusside Injection Revenue Market Share by Region (2021–2032)

Figure 33. China Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. China Taiwan Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Southeast Asia Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Latin America Sodium Nitroprusside Injection Sales Market Share by Country (2021–2032)

Figure 41. Latin America Sodium Nitroprusside Injection Revenue Market Share by Country (2021–2032)

Figure 42. Mexico Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Brazil Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Argentina Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Colombia Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Middle East and Africa Sodium Nitroprusside Injection Sales Market Share by Country (2021–2032)

Figure 47. Middle East and Africa Sodium Nitroprusside Injection Revenue Market Share by Country (2021–2032)

Figure 48. Turkey Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Saudi Arabia Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. UAE Sodium Nitroprusside Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Global Sales Market Share of Sodium Nitroprusside Injection by Type (2021–2032)

Figure 52. Global Revenue Market Share of Sodium Nitroprusside Injection by Type (2021–2032)

Figure 53. Global Sodium Nitroprusside Injection Price (US$/Unit) by Type (2021–2032)

Figure 54. Global Sales Market Share of Sodium Nitroprusside Injection by Application (2021–2032)

Figure 55. Global Revenue Market Share of Sodium Nitroprusside Injection by Application (2021–2032)

Figure 56. Global Sodium Nitroprusside Injection Price (US$/Unit) by Application (2021–2032)

Figure 57. Sodium Nitroprusside Injection Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions